Aruma Labs Partners With Applied Cannabis Research For Endometriosis Observational Study

The condition currently affects approximately 11% of Australian women and could be costing the economy up to $4 billion per annum.There was big news earlier this week from Applied Cannabis Research—which operates as a division of Southern Cannabis Holdings—after a new research partnership with the Australian Life Sciences company Aruma Labs was announced.

The company will officially join the scientific research organization’s CA Clinics Observational Study (CACOS)—which is Australia’s longest running observational study of medicinal marijuana products—with a with a focus on collecting data from patients with endometriosis.

– Read the entire article at Benzinga.

Read More Here…

Share on facebook
Share on twitter
Share on reddit
Share on pinterest
Share on email

Bud Digest

Scroll to Top